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ORIGINAL ARTICLE

FREQUENCY, INDICATIONS AND COMPLICATIONS OF PULMONARY
ARTERY CATHETER INSERTION IN ADULT OPEN-HEART SURGERY
PATIENTS OF A TERTIARY CARE HOSPITAL
Syed Shabbir Ahmed, Mohammad Irfan Akhtar, Rehana Kamal
Department of Anaesthesiology, Aga Khan University, Karachi-Pakistan

Background: Patients presenting for cardiac surgery have unstable cardiovascular disease
and haemodynamics with multiple coexisting diseases. Optimal monitoring in the
perioperative period is very important for best perioperative outcome. The introduction of the
flow-directed pulmonary artery catheter (PAC) into clinical practice is one of the most
important and popular advances in the field of cardiac anaesthesia. The objective of the study
was to determine the frequency, indications and complications of pulmonary artery catheter
insertion in adult open-heart surgery patients. Methods: A Prospective observational study
was conducted at cardiac operating rooms and Cardiac Intensive care unit (CICU) of Aga
Khan University Hospital for a period of six months from Nov 2015 to April 2016.Two
hundred and seven patients were included in this study. PAC was inserted through right/left
internal jugular vein or subclavian vein. Complications noted were arrhythmias (atrial and
ventricular), right bundle branch block, coiling and knotting, pulmonary artery rupture, and
infection up to 72 hours of PAC insertion. Frequency and percentage were computed for
gender, comorbids (Hypertension, Diabetes, Chronic kidney disease, Chronic Obstructive
Pulmonary Disease) and PAC frequency of insertion, indications and complications were
noted. Results: The frequency of PAC insertion was 47.83%. Major indications for PAC
insertion were poor left ventricular function, acute coronary syndrome, cardiogenic shock,
significant left main disease and valvular heart disease patients. Minor complications were
found in 23.22% cases, which included arrhythmia in 19.2% cases and coiling in 4.02%.
Conclusion: Pulmonary artery catheter insertion is a safe technique with useful clinical
application in the management of high-risk cardiac surgical patients. The PAC insertion
rationale must be standardized to confirm the judicious use.
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INTRODUCTION
Patients presenting for cardiac surgery have
unstable
cardiovascular
disease
and
haemodynamics with multiple coexisting diseases.
Optimal monitoring in the perioperative period is
very important for best perioperative outcome. The
introduction of the flow-directed pulmonary artery
catheter (PAC) into clinical practice is one of the
most important and popular advances in the field
of cardiac anaesthesia.1, 2
PAC monitoring provides information
about pulmonary artery occlusion pressure, cardiac
output (CO), right atrial pressure, systemic
vascular resistance and mixed venous O2 (SvO2)
and help us in patients management and may
reduce perioperative mortality and morbidity.3,4 It
has been over used frequently without proper
indications in both the operating rooms and the
ICUs.5,6 There has been considerable controversy
regarding the use of pulmonary artery catheter
(PAC) in clinical practice because of its
complications. In practice, PAC is still used with

frequency of 35–68.2%7,8 and complication rate
reported is around 5–10%9,10.
Different alternate monitoring techniques
can be used in open-heart cardiac surgery, but none
has been proved to be a true replacement of PAC
monitoring. Transoesophageal echocardiography
(TEE) is a valuable monitoring technique both
during and after cardiac surgery. However, its
limitations are that it is a semi-quantitative method
and it does not permit continuous monitoring.
Different practices exist among the
cardiac anaesthesia consultants and cardiac
surgeons regarding the rationale for PA catheter
usage. No local guidelines are available for the use
of PA catheter insertion. Local data is not available
regarding the frequency and rationale of PA
catheter insertion in open-heart cardiac surgery
patients in the developing countries like Pakistan
where health care cost is a major factor. Every
monitoring technique should be rationalized so as
to take optimal advantage of its use economically
and clinically. This audit will help us in gauging
our clinical practice with international practice.
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MATERIAL AND METHODS
After taking approval from Ethical review
committee (Approval no: 3792-Ane-ERC-15) and
informed consent from the patients, this prospective
observational study was conducted in Cardiac
operating room and CICU of tertiary care hospital
for a period of six months. All adult male and
female elective, urgent and emergent open heart
surgery patients including coronary artery bypass
grafting (First time and Redo CABG), isolated
Valve replacements (mitral valve replacements,
aortic valve replacements), combined procedures
(CABG plus Valve replacements) and aortic root
replacements in the age group 18–80 years were
included in the study.
Patients with right atrial thrombus,
endocarditis involving tricuspid and pulmonary
valve, patients with severe pulmonary stenosis, and
patients in which PAC retained for more than 72
hours were excluded.
Sample size calculation was based on
previous studies, where insertion of pulmonary
artery catheter (PAC) was reported in 35%
patients.7,8 Therefore 207 patients were included to
estimate the frequency of PAC insertion within
6.5% level of precision with 95% confidence
interval. Decision of PAC insertion was taken by the
Anaesthesia consultant on list and if ambiguous in
consultation with the Cardiac surgeon. PAC was
inserted through internal jugular or subclavian vein.
Pressure waveforms and filling chamber pressures
guided the floatation of PAC. Complications noted
were arrhythmias (atrial and ventricular), right
bundle branch block, coiling and knotting, RV
rupture, pulmonary artery rupture, and PAC related
infection up to 72 hours post-operatively.
All statistical analyses were performed
using SPSS-19. Frequency and percentage were
computed for gender, comorbids (HTN, DM, CKD,
and COPD) and PAC frequency of insertion,
indications and complications noted. Mean and
standard deviation were also estimated for age,
weight, height and BMI. Stratification was also
performed to control the effect of age, gender, BMI,
comorbid to observe the PAC frequency of
insertion, indications and its complications. Chisquare test was used; p≤0.05 was considered level
of significance.

RESULTS
A total of 207 open-heart cardiac surgery patients
were enrolled in this study, but 204 patients were
followed for 72 hours because 3(1.45%) patients
died during surgery and out of 3 patients only 2
patients received PAC. Nine patients were not
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followed after 72 hours because PAC was retained
beyond the standardized duration. Only one patient
received PAC postoperatively due to eventful postpump course.
The mean age of the patients was 57.76±11.59.
There were 157 (75.85%) male and 50 (24.15%)
female patients. Demographic data is elaborated in
table-1. Most of the cases were CABGs (81.2%),
13% were valve replacements 4.8% cases were
combined procedures and only 1% were ASD
closure.8.2% cases were emergent and all received
PAC. Out of 207 patients, 99 (47.83%) were
monitored with PAC. Major indications were
analysed in the study shown in Figure-1.
Minor complications were found in 23.22%
cases, which included arrhythmia in 19.2%, and
coiling was found in 4.02% cases. These
complications were managed after withdrawing or
manipulation of PAC; only one patient had recurrent
arrhythmias in which PAC was removed
postoperatively within few hours. No major
complications like PA or RV rupture were found.

Figure-1: Frequency and indications of
pulmonary artery catheter (PAC) insertion in
adult open-heart surgery patients
Table-1: Demographic characteristics of patients
(n=207)
Variables
Age (Years)
57.76±11.59
Weight (Kg)
71.66±11.78
Height (cm)
163.54±7.29
BMI (kg/m2)
26.78±4.07
Gender
Male
157 (75.85%)
Female
50 (24.15%)
Co-Morbid:
Hypertension
130 (62.8%)
Diabetic Mellitus
82 (39.6%)
Ischemic heart disease
55(26.6%)
Chronic kidney disease (CKD)
10 (4.8%)
Hypothyroidism
7 (3.4%)
Chronic obstructed pulmonary disease (COPD)
6 (2.9%)
Acute myocardial infarction (AMI)
4 (1.9%)
Other
6 (2.9%)
Other: Asthma, Hepatits C, Valvular heart disease, Rheumatic
heart disease, Acute kidney injury.
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Table-2: Angiographic finding and procedure
(n=207)
Variables
n (%)
Angiographic finding
Grading of coronary artery disease
Normal Vessel
25 (12.1)
Single Vessel
2 (1)
Double Vessel
15 (7.2)
Triple Vessel
165 (79.7)
Significant left main disease
Yes
23 (11.1)
No
184 (88.9)
Ejection Fraction (%)
49.88±12.88
Pulmonary Hypertension
34 (16.4)
Mild
17
Moderate
12
Severe
5
Procedure
CABG
168 (81.2)
Mitral valve replacement (2 of 15 redo MVR)
15 (7.2)
Aortic valve replacement
6 (2.9)
Double valve replacement
6 (2.9)
CABG + AVR/MVR
10 (4.8)
Atrial septal defect
2 (1)
Urgency of procedure
Elective
181 (87.4)
Urgent
9 (4.3)
Emergent
17 (8.2)
Results are presented as n (%) and mean±SD

Table-3: Frequency of complications related to
PAC insertion (n=99)
Complications
Arrhythmias: Atrial
(A. Fibrillation, A. flutter)
Ventricular
(Pre-mature Ventricular
Contractions, Ventricular –
Tachycardia. V- Fibrillation.)
Coiling

Frequency

Percentage

9

9.1

10

10.1

4

4.04

Table 4: Comparison of characteristics with and
without PAC
Variables
Age (Years)
Weight (Kg)
Height (cm)
BMI (kg/m2)
Gender
Male
Female
Co-Morbid:
Hypertension
Diabetic Mellitus
IHD
CKD
Hypothyroidism
COPD
AMI
Other

PAC
Used
n=99
56.43±13.19
70.27±11.89
162.84±7.52
26.55±4.64

PAC
Not Used
n=108
58.98±9.80
72.94±11.58
164.18±7.0
26.99±3.49

72 (72.7%)
27 (27.3%)

85 (78.7%)
23 (21.3%)

0.31

62 (62.6%)
43 (43.4%)
26 (26.3%)
10 (10.1%)
6 (6.1%)
4 (4%)
3 (3%)
5 (5.1%)

68 (63%)
39 (36.1%)
29 (26.9%)
0 (0%)
1 (0.9%)
2 (1.9%)
1 (0.9%)
1 (0.9%)

0.96
0.28
0.92
0.001
0.041
0.34
0.27
0.07

p-values
0.11
0.10
0.18
0.44

Table-5: Comparison of Angiographic finding and
procedure with and without PAC (n=207)
Variables
Angiographic finding
Grading OF CAD
Normal Vessel
Single Vessel
Double Vessel
Triple Vessel
Significant left main disease
Yes
No
Ejection Fraction (%)
Pulmonary Hypertension
Mild
Moderate
Severe
Procedure
CABG
MVR (2 of 15 redo MVR)
AVR
DVR
CABG + AVR/MVR
ASD
Urgency of Procedure
Elective
Urgent
Emergent

PAC Used
n=99

PAC
Not Used
n=108

p-Value

22 (22.2%)
1 (1%)
6(6.1%)
70 (70.7%)

3 (2.8%)
1 (0.9%)
9 (8.3%)
95 (88%)

0.0005
0.99
0.59
0.002

16 (16.2%)
7 (6.5%)
0.027
83 (83.8%) 101 (93.5%)
44.60±14.24 55.11±8.68 0.0005
23 (23.2%) 11 (10.2%)
8
9
0.011
10
2
5
0
67 (67.7%) 101 (93.5%) 0.0005
14 (14.1%)
1 (0.9%)
0.0005
5 (5.1%)
1 (0.9%)
0.106
6 (6.1%)
0 (0.0%)
0.011
7 (7.1%)
3 (2.8%)
0.19
0 (0%)
2 (1.9%)
0.49
73 (73.7%) 108 (100%)
9 (9.1%)
0 (0%)
17 (17.2%)
0 (0%)

0.0005

DISCUSSION
Pulmonary artery catheter was proudly announced
first in 1970,11 then grew rapidly and gained
popularity till 1986, after that it was challenged in
clinical practice. There has been considerable
controversy regarding the use of pulmonary artery
catheter (PAC) in clinical practice.12,13 Many studies
have indicated poor outcome in patients who were
monitored with PAC.10 However, these studies, that
have condemned the use of PAC, were conducted on
patients in intensive care units, where the clinical
scenarios with regard to patients clinical status were
somewhat different as compared to those of cardiac
operating room.9 Although some studies disapproved
PAC in cardiac surgery6,8 but still studies proved that
PAC is used more as monitoring tool in cardiac
surgery than any other monitoring devices14. The use
of PAC in cardiac surgeries varies considerably from
a routine use to no PAC at all and majority follow
indications, which we followed in this study.
Although guidelines for PAC insertion are available
in non-cardiac surgeries, 15 none are available for
adult cardiac surgical patients undergoing open-heart
procedures.
No PAC related study has been conducted in
cardiac surgery patients in Pakistan. Our institution is
one of the leading centres for cardiac surgeries in
Pakistan, where around 800–1000 adult open-heart
surgeries are performed yearly. We routinely use
PAC for monitoring in high risk cardiac surgery
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patients including Acute coronary syndrome, valve
replacements, poor LV and cardiogenic shock,
therefore we had designed and conducted this study
to share our experience about PAC with respect to its
frequency of insertion, indications and complications.
In our clinical practice, PAC insertion has been found
to be very useful in differentiating between
cardiogenic and vasoplegic shock. PAC also helps in
rational and objective use of inotropes and
vasopressors.
The current study showed that PAC was
used in 47.83% of enrolled cases of which majority
were elective triple vessel coronary artery disease
patients scheduled for CABG. We used PAC in
almost all valve replacement surgeries and
emergent/urgent cardiac surgeries. Surgeon choice
was found in very few cases. There were few cases in
which we didn’t use PAC despite poor LV function.
There were no major complications except
arrhythmias 19.2% and coiling 4.04% of patients, all
of which were settled by just withdrawing or readjustment of catheter. Literature showed that rate of
major complications related to PAC is low in cardiac
surgery and also when inserted and managed by an
experienced Anaesthesiologist/Intensivist.16. There is
wide range of complications mostly related to
arrhythmias
12.0–70%
reported.16
Other
complications like thrombosis (8–22%), endocarditis
(2.2-7.1%), PA rupture (0.03–0.20%), knotting
(0.03%), sepsis (1.3-2.2%) were reported in western
literature.16,17 If we compared this study with the
other study on PAC in ICU conducted at Aga khan
university hospital in 2006, the frequency of PAC
insertion was 19% and complication rate was 30%.18
We did not analyze the cost of PAC in
cardiac surgery but roughly it cost about 15,000–
17,000 PKR per PAC, so in developing country like
Pakistan risk and benefit ratio should be considered
while placement of PAC.
In cardiac surgeries there are some other non-invasive
or semi invasive cardiac output monitoring devices
available like Pulse index continuous cardiac output
(PiCCO), lithium dilution cardiac output (LidCO),
Bio-impedance, Oesophageal Doppler, with very
limited data available.14 Among all of these
monitoring
devices
Trans-oesophageal
echocardiography (TEE) is an alternating tool for
monitoring in cardiac surgery.19 TEE is one of the
evolving modality with standard of care application
in many international cardiac centres. TEE needs
expertise and experience for continual monitoring. At
present, cardiac Anaesthesiologist’s choice of PAC or
TEE monitoring is strongly influenced by their
expertise and availability. PAC and TEE are not
competitors; albeit they are subsidiary monitoring
tools. Of course, the definition of correct use and a
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correct indication may vary according to local policy,
economic considerations and the patient population.
The limitation of the study is that it is a
prospective observational study with no comparison
with any other cardiac monitoring modality and no
standardization in the choice of PAC. The choice of
PAC insertion was predominantly at the discretion of
the cardiac anaesthesiologist. The study was limited
to 72 hours’ post-operative period with no data
collection of long-term mortality and morbidity.

CONCLUSION
Pulmonary artery catheter insertion is safe technique
with useful clinical application in the management of
high-risk cardiac surgical patients. Risk benefit ratio
must be considered during the selection of PAC
insertion. The PAC insertion rationale must be
standardized to confirm the judicious use.
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